Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 831-833

  De Wit, Ronald ^a   Louwerens, Marloes ^a   De Mulder, Pieter H M ^b   Verweij, Jaap ^a   Rodenhuis, Sjoerd ^c   Schornagel, Jan ^c  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; GERM CELL TUMOR; HUMAN; MALE; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA; CISPLATIN; ETOPOSIDE; GERMINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PACLITAXEL; PROGNOSIS; TESTICULAR NEOPLASMS;

EID: 0032735907     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991210)83:6<831::AID-IJC24>3.0.CO;2-O     Document Type: Conference Paper

References (10)

1. BOKEMEYER, C., FEYER, J., METZNER, B., RÜTHER, U., HARSTRICK, A., WEISSBACH, L., KÖHRMANN, U., VERBEEK, W. and SCHMOLL, H.J., Phase II study of paclitaxel in patients with relapsed or cisplatin refractory testicular cancer. Ann. Oncol, 7, 31-40 (1996).
2. DE WIT, R., STOTER, G., SLEIJFER, D.TH., NEIJT, J.P., TEN BOKKEL HUININK, W.W., DE PRIJCK, L., COLLETTE, L. and SYLVESTER, R., Four cycles of BEP vs four cycles of VIP in patients with intermeditate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. Brit. J. Cancer, 78, 828-832 (1998).
3. EINHORN, L.H., Treatment of testicular cancer: a new and improved model. J. clin. Oncol., 8, 1717-1781 (1990).
4. FOSSÅ, S.D., KAYE, S.B., MEAD, G.M., CULLEN, M., DE WIT, R., BODROGI, I., VAN GROENINGEN, C.J., DE MULDER, P.H.M., STENNING, S., LALLEMAND, E., DE PRIJCK, L. and COLLETTE, L., Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. J. clin. Oncol. 16, 716-724 (1998).
5. INTERNATIONAL GERM CELL CANCER COLLABORATIVE GROUP, INTERNATIONAL GERM CELL CONSENSUS CLASSIFICATION. A prognostic factor-based staging system for metastatic germ cell cancers by the International Germ Cell Cancer Collaborative Group (IGCCCG). J. clin. Oncol., 15, 594-603 (1997).
6. KAYE, S.B. and 12 others, Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. J. clin. Oncol., 16, 692-701 (1998).
7. MOTZER, R.J., BAJORIN, D.F., SCHWARTZ, L.H., HUTTER, H.S., BOSL, G.J., SCHER, H.I., LYN, P. and FISCHER, P., Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J. clin. Oncol., 12, 2277-2283 (1994).
8. NICHOLS, C.R., CATALANO, P.J., CRAWFORD, E.D., VOGELZANG, N.J., EINHORN, L.H. and LOEHRER, P.J., Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumours: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study. J. clin. Oncol., 16, 1287-1293 (1998).
9. NICHOLS, C.R., WILLIAMS, S.D., LOEHRER, P.J., GRECO, F.A., CRAWFORD, E.D., WEETLAUFER, J., MILLER, M.E., BARTOLUCCI, A., SCHACTER, L. and EINHORN, L.H., Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J. clin. Oncol., 9, 1163-1172 (1991).
10. TJAN-HEIJNEN, V.C.G., OOSTERHOF, G.O.N., DE WIT, R. and DE MULDER, P.M.M., Treatment in germ cell tumours: state of the art. Europ. J. surg. Oncol., 23, 110-122 (1997).